BELSOMRA
These highlights do not include all the information needed to use BELSOMRA safely and effectively. See full prescribing information for BELSOMRA. BELSOMRA (suvorexant) tablets, for oral use, C-IV Initial U.S. Approval: 2014
e5b72731-1acb-45b7-9c13-290ad12d3951
HUMAN PRESCRIPTION DRUG LABEL
Feb 28, 2023
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
suvorexant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
suvorexant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
suvorexant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
suvorexant
Product Details
FDA regulatory identification and product classification information